Excess in the pharmaceutical industry
- PMID: 15583183
- PMCID: PMC534578
- DOI: 10.1503/cmaj.1041594
Excess in the pharmaceutical industry
References
-
- Pattison N, Warren L. 2002 drug industry profits: hefty pharmaceutical company margins dwarf other industries. Washington (DC): Public Citizen Congress Watch; June 2003. Available: www.citizen.org/documents/Pharma_Report.pdf (accessed 2004 Nov 3).
-
- Fortune 500: How the industries stack up. Fortune 2004;149(7):F26.
-
- Bouton D, editor. Out-of-bounds: rising prescription drug prices for seniors. Publ no 03-106. Washington (DC): Families USA; July 2003. Available: www.familiesusa.org (accessed 2004 Nov 4).
-
- Hensley S. Drug prices rise at faster clip, placing burden on consumers. Wall Street Journal 2003 Apr 15;Sect D:4.
-
- US Food and Drug Administration Center for Drug Evaluation and Research, Department of Health and Human Services. NDAs approved in calendar years 1990–2003 by therapeutic potentials and chemical types. Jan 21, 2004. Available: www.fda.gov/cder/rdmt/pstable.htm (accessed 2004 Nov 3).
MeSH terms
LinkOut - more resources
Full Text Sources